0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-37D11956
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Varicella Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-37D11956
Report
September 2022
108 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Varicella Vaccine market is projected to reach US$ 7104.7 million by 2028 from an estimated US$ 4527.3 million in 2022, at a CAGR of 7.8% during 2023 and 2028.

Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.

Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.
The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Product Type Insights
Global markets are presented by Varicella Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Varicella Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Varicella Vaccine Segment by Type

Injection
Freeze-Dried Powder
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Varicella Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Varicella Vaccine market.

Varicella Vaccine Segment by Application

Kids Injection
Adults Injection
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Varicella Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varicella Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Varicella Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Varicella Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varicella Vaccine

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Varicella Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Varicella Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Market by Application
1.3.1 Global Varicella Vaccine Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Varicella Vaccine Market Size Estimates and Forecasts
2.1.1 Global Varicella Vaccine Revenue 2017-2028
2.1.2 Global Varicella Vaccine Sales 2017-2028
2.2 Varicella Vaccine Market Size by Region: 2022 Versus 2028
2.3 Varicella Vaccine Sales by Region (2017-2028)
2.3.1 Global Varicella Vaccine Sales by Region: 2017-2022
2.3.2 Global Varicella Vaccine Sales Forecast by Region (2023-2028)
2.3.3 Global Varicella Vaccine Sales Market Share by Region (2017-2028)
2.4 Varicella Vaccine Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Varicella Vaccine Revenue by Region: 2017-2022
2.4.2 Global Varicella Vaccine Revenue Forecast by Region (2023-2028)
2.4.3 Global Varicella Vaccine Revenue Market Share by Region (2017-2028)
3 Global Varicella Vaccine by Manufacturers
3.1 Global Top Varicella Vaccine Manufacturers by Sales
3.1.1 Global Varicella Vaccine Sales by Manufacturer (2017-2022)
3.1.2 Global Varicella Vaccine Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Varicella Vaccine Manufacturers by Revenue
3.2.1 Global Varicella Vaccine Revenue by Manufacturer (2017-2022)
3.2.2 Global Varicella Vaccine Revenue Share by Manufacturer (2017-2022)
3.3 Global Varicella Vaccine Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Varicella Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Varicella Vaccine Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Varicella Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Varicella Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Varicella Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Varicella Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merck
4.1.1 Merck Corporation Information
4.1.2 Merck Description, Business Overview
4.1.3 Merck Varicella Vaccine Products Offered
4.1.4 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Merck Varicella Vaccine Sales by Product in 2021
4.1.6 Merck Varicella Vaccine Sales by Application in 2021
4.1.7 Merck Varicella Vaccine Sales by Geographic Area in 2021
4.1.8 Merck Recent Developments
4.2 GSK
4.2.1 GSK Corporation Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK Varicella Vaccine Products Offered
4.2.4 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.2.5 GSK Varicella Vaccine Sales by Product in 2021
4.2.6 GSK Varicella Vaccine Sales by Application in 2021
4.2.7 GSK Varicella Vaccine Sales by Geographic Area in 2021
4.2.8 GSK Recent Developments
4.3 Shanghai Institute
4.3.1 Shanghai Institute Corporation Information
4.3.2 Shanghai Institute Description, Business Overview
4.3.3 Shanghai Institute Varicella Vaccine Products Offered
4.3.4 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Shanghai Institute Varicella Vaccine Sales by Product in 2021
4.3.6 Shanghai Institute Varicella Vaccine Sales by Application in 2021
4.3.7 Shanghai Institute Varicella Vaccine Sales by Geographic Area in 2021
4.3.8 Shanghai Institute Recent Developments
4.4 BCHT
4.4.1 BCHT Corporation Information
4.4.2 BCHT Description, Business Overview
4.4.3 BCHT Varicella Vaccine Products Offered
4.4.4 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.4.5 BCHT Varicella Vaccine Sales by Product in 2021
4.4.6 BCHT Varicella Vaccine Sales by Application in 2021
4.4.7 BCHT Varicella Vaccine Sales by Geographic Area in 2021
4.4.8 BCHT Recent Developments
4.5 Changsheng
4.5.1 Changsheng Corporation Information
4.5.2 Changsheng Description, Business Overview
4.5.3 Changsheng Varicella Vaccine Products Offered
4.5.4 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Changsheng Varicella Vaccine Sales by Product in 2021
4.5.6 Changsheng Varicella Vaccine Sales by Application in 2021
4.5.7 Changsheng Varicella Vaccine Sales by Geographic Area in 2021
4.5.8 Changsheng Recent Developments
4.6 Keygen
4.6.1 Keygen Corporation Information
4.6.2 Keygen Description, Business Overview
4.6.3 Keygen Varicella Vaccine Products Offered
4.6.4 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Keygen Varicella Vaccine Sales by Product in 2021
4.6.6 Keygen Varicella Vaccine Sales by Application in 2021
4.6.7 Keygen Varicella Vaccine Sales by Geographic Area in 2021
4.6.8 Keygen Recent Development
4.7 Green Cross
4.7.1 Green Cross Corporation Information
4.7.2 Green Cross Description, Business Overview
4.7.3 Green Cross Varicella Vaccine Products Offered
4.7.4 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Green Cross Varicella Vaccine Sales by Product in 2021
4.7.6 Green Cross Varicella Vaccine Sales by Application in 2021
4.7.7 Green Cross Varicella Vaccine Sales by Geographic Area in 2021
4.7.8 Green Cross Recent Development
4.8 Biken
4.8.1 Biken Corporation Information
4.8.2 Biken Description, Business Overview
4.8.3 Biken Varicella Vaccine Products Offered
4.8.4 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Biken Varicella Vaccine Sales by Product in 2021
4.8.6 Biken Varicella Vaccine Sales by Application in 2021
4.8.7 Biken Varicella Vaccine Sales by Geographic Area in 2021
4.8.8 Biken Recent Development
5 Breakdown Data by Type
5.1 Global Varicella Vaccine Sales by Type (2017-2028)
5.1.1 Global Varicella Vaccine Sales by Type (2017-2022)
5.1.2 Global Varicella Vaccine Sales Forecast by Type (2023-2028)
5.1.3 Global Varicella Vaccine Sales Market Share by Type (2017-2028)
5.2 Global Varicella Vaccine Revenue Forecast by Type (2017-2028)
5.2.1 Global Varicella Vaccine Revenue by Type (2017-2022)
5.2.2 Global Varicella Vaccine Revenue Forecast by Type (2023-2028)
5.2.3 Global Varicella Vaccine Revenue Market Share by Type (2017-2028)
5.3 Varicella Vaccine Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Varicella Vaccine Sales by Application (2017-2028)
6.1.1 Global Varicella Vaccine Sales by Application (2017-2022)
6.1.2 Global Varicella Vaccine Sales Forecast by Application (2023-2028)
6.1.3 Global Varicella Vaccine Sales Market Share by Application (2017-2028)
6.2 Global Varicella Vaccine Revenue Forecast by Application (2017-2028)
6.2.1 Global Varicella Vaccine Revenue by Application (2017-2022)
6.2.2 Global Varicella Vaccine Revenue Forecast by Application (2023-2028)
6.2.3 Global Varicella Vaccine Revenue Market Share by Application (2017-2028)
6.3 Varicella Vaccine Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Varicella Vaccine Market Size YoY Growth 2017-2028
7.2 North America Varicella Vaccine Market Facts & Figures by Country
7.2.1 North America Varicella Vaccine Sales by Country (2017-2028)
7.2.2 North America Varicella Vaccine Revenue by Country (2017-2028)
7.3 North America Varicella Vaccine Sales by Type
7.4 North America Varicella Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Varicella Vaccine Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Varicella Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Varicella Vaccine Sales by Region (2017-2028)
8.2.2 Asia-Pacific Varicella Vaccine Revenue by Region (2017-2028)
8.3 Asia-Pacific Varicella Vaccine Sales by Type
8.4 Asia-Pacific Varicella Vaccine Sales by Application
9 Europe
9.1 Europe Varicella Vaccine Market Size YoY Growth 2017-2028
9.2 Europe Varicella Vaccine Market Facts & Figures by Country
9.2.1 Europe Varicella Vaccine Sales by Country (2017-2028)
9.2.2 Europe Varicella Vaccine Revenue by Country (2017-2028)
9.3 Europe Varicella Vaccine Sales by Type
9.4 Europe Varicella Vaccine Sales by Application
10 Latin America
10.1 Latin America Varicella Vaccine Market Size YoY Growth 2017-2028
10.2 Latin America Varicella Vaccine Market Facts & Figures by Country
10.2.1 Latin America Varicella Vaccine Sales by Country (2017-2028)
10.2.2 Latin America Varicella Vaccine Revenue by Country (2017-2028)
10.3 Latin America Varicella Vaccine Sales by Type
10.4 Latin America Varicella Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Varicella Vaccine Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Varicella Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Varicella Vaccine Sales by Country (2017-2028)
11.2.2 Middle East and Africa Varicella Vaccine Revenue by Country (2017-2028)
11.3 Middle East and Africa Varicella Vaccine Sales by Type
11.4 Middle East and Africa Varicella Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Varicella Vaccine Supply Chain Analysis
12.2 Varicella Vaccine Key Raw Materials and Upstream Suppliers
12.3 Varicella Vaccine Clients Analysis
12.4 Varicella Vaccine Sales Channel and Sales Model Analysis
12.4.1 Varicella Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Varicella Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Varicella Vaccine Distributors
13 Market Dynamics
13.1 Varicella Vaccine Industry Trends
13.2 Varicella Vaccine Market Drivers
13.3 Varicella Vaccine Market Challenges
13.4 Varicella Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Varicella Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Injection
    Table 3. Major Manufacturers of Freeze-Dried Powder
    Table 4. Global Varicella Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Varicella Vaccine Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 6. Global Varicella Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 7. Global Varicella Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
    Table 8. Global Varicella Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 9. Global Varicella Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 10. Global Varicella Vaccine Sales by Manufacturer (2017-2022) & (M Doses)
    Table 11. Global Varicella Vaccine Sales Share by Manufacturer (2017-2022)
    Table 12. Varicella Vaccine Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 13. Varicella Vaccine Revenue Share by Manufacturer (2017-2022)
    Table 14. Key Manufacturers Varicella Vaccine Price (2017-2022) & (USD/Dose)
    Table 15. Ranking of Global Top Varicella Vaccine Manufacturers by Revenue (US$ Million) in 2021
    Table 16. Global Varicella Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 17. Global Varicella Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Varicella Vaccine as of 2021)
    Table 18. Varicella Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Varicella Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Varicella Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Merck Corporation Information
    Table 23. Merck Description and Business Overview
    Table 24. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 25. Merck Varicella Vaccine Product
    Table 26. Merck Varicella Vaccine Sales Proportion of Varicella Vaccine by Product in 2021
    Table 27. Merck Varicella Vaccine Sales Proportion of Varicella Vaccine by Application in 2021
    Table 28. Merck Varicella Vaccine Sales Proportion of Varicella Vaccine by Geographic Area in 2021
    Table 29. Merck Recent Development
    Table 30. GSK Corporation Information
    Table 31. GSK Description and Business Overview
    Table 32. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 33. GSK Varicella Vaccine Product
    Table 34. GSK Varicella Vaccine Sales Proportion of Varicella Vaccine by Product in 2021
    Table 35. GSK Varicella Vaccine Sales Proportion of Varicella Vaccine by Application in 2021
    Table 36. GSK Varicella Vaccine Sales Proportion of Varicella Vaccine by Geographic Area in 2021
    Table 37. GSK Recent Development
    Table 38. Shanghai Institute Corporation Information
    Table 39. Shanghai Institute Description and Business Overview
    Table 40. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 41. Shanghai Institute Varicella Vaccine Product
    Table 42. Shanghai Institute Varicella Vaccine Sales Proportion of Varicella Vaccine by Product in 2021
    Table 43. Shanghai Institute Varicella Vaccine Sales Proportion of Varicella Vaccine by Application in 2021
    Table 44. Shanghai Institute Varicella Vaccine Sales Proportion of Varicella Vaccine by Geographic Area in 2021
    Table 45. Shanghai Institute Recent Development
    Table 46. BCHT Corporation Information
    Table 47. BCHT Description and Business Overview
    Table 48. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 49. BCHT Varicella Vaccine Product
    Table 50. BCHT Varicella Vaccine Sales Proportion of Varicella Vaccine by Product in 2021
    Table 51. BCHT Varicella Vaccine Sales Proportion of Varicella Vaccine by Application in 2021
    Table 52. BCHT Varicella Vaccine Sales Proportion of Varicella Vaccine by Geographic Area in 2021
    Table 53. BCHT Recent Development
    Table 54. Changsheng Corporation Information
    Table 55. Changsheng Description and Business Overview
    Table 56. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 57. Changsheng Varicella Vaccine Product
    Table 58. Changsheng Varicella Vaccine Sales Proportion of Varicella Vaccine by Product in 2021
    Table 59. Changsheng Varicella Vaccine Sales Proportion of Varicella Vaccine by Application in 2021
    Table 60. Changsheng Varicella Vaccine Sales Proportion of Varicella Vaccine by Geographic Area in 2021
    Table 61. Changsheng Recent Development
    Table 62. Keygen Corporation Information
    Table 63. Keygen Description and Business Overview
    Table 64. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. Keygen Varicella Vaccine Product
    Table 66. Keygen Varicella Vaccine Sales Proportion of Varicella Vaccine by Product in 2021
    Table 67. Keygen Varicella Vaccine Sales Proportion of Varicella Vaccine by Application in 2021
    Table 68. Keygen Varicella Vaccine Sales Proportion of Varicella Vaccine by Geographic Area in 2021
    Table 69. Green Cross Corporation Information
    Table 70. Green Cross Description and Business Overview
    Table 71. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 72. Green Cross Varicella Vaccine Product
    Table 73. Green Cross Varicella Vaccine Sales Proportion of Varicella Vaccine by Product in 2021
    Table 74. Green Cross Varicella Vaccine Sales Proportion of Varicella Vaccine by Application in 2021
    Table 75. Green Cross Varicella Vaccine Sales Proportion of Varicella Vaccine by Geographic Area in 2021
    Table 76. Biken Corporation Information
    Table 77. Biken Description and Business Overview
    Table 78. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 79. Biken Varicella Vaccine Product
    Table 80. Biken Varicella Vaccine Sales Proportion of Varicella Vaccine by Product in 2021
    Table 81. Biken Varicella Vaccine Sales Proportion of Varicella Vaccine by Application in 2021
    Table 82. Biken Varicella Vaccine Sales Proportion of Varicella Vaccine by Geographic Area in 2021
    Table 83. Global Varicella Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 84. Global Varicella Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
    Table 85. Global Varicella Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Global Varicella Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 87. Global Varicella Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 88. Global Varicella Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
    Table 89. Global Varicella Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Global Varicella Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 91. North America Varicella Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 92. North America Varicella Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 93. North America Varicella Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 94. North America Varicella Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 95. North America Varicella Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 96. North America Varicella Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 97. Asia-Pacific Varicella Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 98. Asia-Pacific Varicella Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 99. Asia-Pacific Varicella Vaccine Revenue by Region (2017-2028) & (US$ Million)
    Table 100. Asia-Pacific Varicella Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 101. Asia-Pacific Varicella Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 102. Asia-Pacific Varicella Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 103. Europe Varicella Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 104. Europe Varicella Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 105. Europe Varicella Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Europe Varicella Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Europe Varicella Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 108. Europe Varicella Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 109. Latin America Varicella Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 110. Latin America Varicella Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 111. Latin America Varicella Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 112. Latin America Varicella Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 113. Latin America Varicella Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 114. Latin America Varicella Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 115. Middle East and Africa Varicella Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 116. Middle East and Africa Varicella Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 117. Middle East and Africa Varicella Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 118. Middle East and Africa Varicella Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 119. Middle East and Africa Varicella Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 120. Middle East and Africa Varicella Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 121. Varicella Vaccine Key Raw Materials, Industry Status and Trend
    Table 122. Varicella Vaccine Key Raw Materials and Upstream Suppliers
    Table 123. Varicella Vaccine Clients Status and Trend
    Table 124. Varicella Vaccine Typical Clients
    Table 125. Varicella Vaccine Distributors
    Table 126. Varicella Vaccine Market Trends
    Table 127. Varicella Vaccine Market Drivers
    Table 128. Varicella Vaccine Market Challenges
    Table 129. Varicella Vaccine Market Restraints
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Varicella Vaccine Product Picture
    Figure 2. Global Varicella Vaccine Sales Market Share by Type in 2021 & 2028
    Figure 3. Injection Product Picture
    Figure 4. Freeze-Dried Powder Product Picture
    Figure 5. Global Varicella Vaccine Sales Market Share by Application in 2021 & 2028
    Figure 6. Kids Injection Examples
    Figure 7. Adults Injection Examples
    Figure 8. Varicella Vaccine Report Years Considered
    Figure 9. Global Varicella Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Varicella Vaccine Market Size 2017-2028 (US$ Million)
    Figure 11. Global Varicella Vaccine Sales 2017-2028 (M Doses)
    Figure 12. Global Varicella Vaccine Market Size Market Share by Region: 2022 Versus 2028
    Figure 13. Global Varicella Vaccine Sales Market Share Forecast by Region (2017-2028)
    Figure 14. Global Varicella Vaccine Revenue Market Share by Region (2017-2028)
    Figure 15. Global Varicella Vaccine Sales Share by Manufacturer in 2021
    Figure 16. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Varicella Vaccine Sales Market Share Forecast by Type (2017-2028)
    Figure 18. Global Varicella Vaccine Revenue Market Share Forecast by Type (2017-2028)
    Figure 19. Varicella Vaccine Average Selling Price (ASP) by Type (2017-2022) & (USD/Dose)
    Figure 20. Global Varicella Vaccine Sales Market Share Forecast by Application (2017-2028)
    Figure 21. Global Varicella Vaccine Revenue Market Share Forecast by Application (2017-2028)
    Figure 22. Varicella Vaccine Average Selling Price (ASP) by Application (2017-2022) & (USD/Dose)
    Figure 23. North America Varicella Vaccine Revenue 2017-2028 (US$ Million)
    Figure 24. North America Varicella Vaccine Sales Market Share by Type (2017-2022)
    Figure 25. North America Varicella Vaccine Sales Market Share by Application (2017-2022)
    Figure 26. Asia-Pacific Varicella Vaccine Revenue 2017-2028 (US$ Million)
    Figure 27. Asia-Pacific Varicella Vaccine Sales Market Share by Region (2017-2028)
    Figure 28. Asia-Pacific Varicella Vaccine Revenue Market Share by Region (2017-2028)
    Figure 29. Asia-Pacific Varicella Vaccine Sales Market Share by Type (2017-2022)
    Figure 30. Asia-Pacific Varicella Vaccine Sales Market Share by Application (2017-2022)
    Figure 31. Europe Varicella Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 32. Europe Varicella Vaccine Sales Market Share by Country (2017-2028)
    Figure 33. Europe Varicella Vaccine Revenue Market Share by Country (2017-2028)
    Figure 34. Europe Varicella Vaccine Sales Market Share by Type (2017-2022)
    Figure 35. Europe Varicella Vaccine Sales Market Share by Application (2017-2022)
    Figure 36. Latin America Varicella Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 37. Latin America Varicella Vaccine Sales Market Share by Country (2017-2028)
    Figure 38. Latin America Varicella Vaccine Revenue Market Share by Country (2017-2022)
    Figure 39. Latin America Varicella Vaccine Sales Market Share by Type (2017-2022)
    Figure 40. Latin America Varicella Vaccine Sales Market Share by Application (2017-2022)
    Figure 41. Middle East and Africa Varicella Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 42. Middle East and Africa Varicella Vaccine Sales Market Share by Country (2017-2028)
    Figure 43. Middle East and Africa Varicella Vaccine Revenue Market Share by Country (2017-2028)
    Figure 44. Middle East and Africa Varicella Vaccine Sales Market Share by Type (2017-2022)
    Figure 45. Middle East and Africa Varicella Vaccine Sales Market Share by Application (2017-2022)
    Figure 46. Varicella Vaccine Supply Chain (Upstream and Downstream Market)
    Figure 47. Global Production Market Share of Varicella Vaccine Raw Materials by Region in 2021
    Figure 48. Varicella Vaccine Distribution Channels
    Figure 49. Global Varicella Vaccine Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 50. Global Varicella Vaccine Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS